Target intelligence / Profile preview

microRNA 4490 (MIR4490)

Target
MIR4490
Molecular classification
Non-coding RNA, MicroRNA
01

Overview

MicroRNA 4490 is a member of the microRNA (miRNA) family—a class of small, non-coding RNAs approximately 22 nucleotides in length, involved in regulating gene expression post-transcriptionally. miRNAs such as MIR4490 are transcribed as primary transcripts (pri-miRNAs), processed into precursor miRNAs (pre-miRNAs) by the Drosha complex in the nucleus, exported to the cytoplasm, and further processed by Dicer to their mature forms. Mature MIR4490 is presumed to bind complementary sequences in the 3′ untranslated regions of specific mRNA targets to inhibit translation or induce degradation, thereby regulating various cellular processes. While the general functions, pathways, and biogenesis mechanisms are well described for miRNAs, specific biological functions, disease associations, or validated mRNA targets for MIR4490 itself are not well established in the major literature surveyed[3][4][2]. microRNA 4490 (MIR4490) is a human microRNA. As a non-coding RNA, it is involved in post-transcriptional regulation of gene expression but is not typically considered a canonical "therapeutic target" such as a receptor or enzyme. There are no well-established interacting drugs or specific disease associations for MIR4490 itself in the consensus literature.

Other names
MIR4490hsa-mir-4490miR-4490
02

Mechanism of action

For therapies targeting microRNAs: Antisense inhibition (antagomirs; designed to bind and inactivate the target miRNA); miRNA mimics (designed to restore or augment downregulated microRNA function); Modulation of RNA interference machinery

03

Biological functions

Regulation of gene expressionCell differentiationCell cycle regulationApoptosisSignal transductionOther regulatory cellular functions
04

Disease associations

CancerInflammationCardiovascular diseaseImmune response and infection
05

Safety considerations

Off-target effects or global disturbance to gene expression networksUnintended effects on multiple unrelated genes due to miRNA target multiplicityDelivery and stability challenges for RNA-based therapeuticsImmunogenicity issues for synthetic miRNA modulators
06

Biomarkers

Circulating levels of specific microRNAs (including potential use of MIR4490 if validated) as non-invasive biomarkers for the diagnosis, prognosis, or monitoring of diseases, especially cancer and inflammation

Beyond the preview

Go deeper on microRNA 4490 (MIR4490).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 4490 (MIR4490).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call